Zydus Lifesciences Ltd. Fundamental & Technical Research, Share Price Today

NSE : ZYDUSLIFE
NIFTY : Nifty Next 50
NIFTY SECTOR : Nifty Pharma

About Company

Zydus Lifesciences Limited (formerly known as Cadila Healthcare Limited), a Company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients (API) and human formulations.

Market Cap. ₹90,752 Cr.

52 Week - High/Low ₹1,324/855

P/E Ratio 20.82

P/B Ratio 5.77

Enterprise Value ₹97,726 Cr.

ROE % 23.45

RSI Value 49.26

EMA 50 918.48

EMA 200 961.21

Net Profit 3,442 Cr.

Net Profit 3year growth 133.13 Cr.

Net Profit 3 year (back) 1,476 Cr.

Debt to Equity 0.39 %

EPS Growth TTM 73.49 %

Current Ratio 2.22 %

100 Day SMA 947 Rs.

200 Day SMA 1,030 Rs.

21 Day SMA 897 Rs.

50 Day SMA 921 Rs.

Book Value 156 Rs.

EV/EBITDA Ratio 15

QoQ EPS Growth -40 %

QoQ Operating Profit Growth -27 %

QoQ Sales Growth -4 %

Sales Latest Quarter 2,409 Cr.

YoY Sales Growth 6 %

Market Cap. ₹90,752 Cr.

52 Week - High/Low ₹1,324/855

P/E Ratio 20.03

P/B Ratio 4.58

Enterprise Value ₹89,840 Cr.

ROE % 20.52

RSI Value 49.26

EMA 50 918.48

EMA 200 961.21

Net Profit 3,860 Cr.

Net Profit 3year growth 6.6 Cr.

Net Profit 3 year (back) 2,134 Cr.

Debt to Equity 0.04 %

EPS Growth TTM 53.27 %

Current Ratio 2.14 %

100 Day SMA 947 Rs.

200 Day SMA 1,030 Rs.

21 Day SMA 897 Rs.

50 Day SMA 921 Rs.

Book Value 197 Rs.

EV/EBITDA Ratio 13

QoQ EPS Growth 12 %

QoQ Operating Profit Growth -2 %

QoQ Sales Growth 1 %

Sales Latest Quarter 5,124 Cr.

YoY Sales Growth 17 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages